Organizing Committee
Michal Lotem
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, Paris, France
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, New York City, USA
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Rome, Italy
Director of the Sharett Institute of Oncology
Hadassah Medical Center, Jerusalem, Israel
Speakers
Head, Division of Oncogenomics
Netherlands Cancer Institute, Amsterdam, The Netherlands
Bruno Amati
Group Leader, Department of Experimental Oncology
European Institute of Oncology (IEO), Milan, Italy
Beatrice Bodega
Principal Investigator, Professor of Molecular Biology, Co-Founder and Consultant
T-One Therapeutics INGM and University of Milan, Italy
Alessandro Bonetti
Director, Early Respiratory
AstraZeneca, Cambridge, UK
Director, Icahn Genomics Institute; Vice Chair, Department of Immunology and Immunotherapy
Icahn School of Medicine at Mount Sinai, New York City, USA
MRC Human Genetics Unit, Institute of Genetics and Cancer
University of Edinburgh, UK
Thomas A. Cooper
S. Donald Greenberg and R. Clarence and Irene H. Fulbright Professor, Department of Pathology and Immunology
Baylor College of Medicine, Houston, USA
Director, Institute of Pharmacology and Toxicology
Technical University of Munich (TUM), Germany
Professor, Bioscience Chair, Center of Excellence for Smart Health Biomedical Sciences
King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, New York City, USA
Danny Incarnato
Associate Professor of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute (GBB)
University of Groningen, The Netherlands
Nadiya Ishnazarova
Principal, Venture Investments
JJDC, Amsterdam, The Netherlands
Rory Johnson
Associate Professor, Laboratory for Genomics of Long Noncoding RNA and Disease
University College Dublin, Ireland
Julian König
Chair of Biochemistry and RNA-Biology, Theodor-Boveri-Institute
Julius Maximilian University of Würzburg, Germany
Kathy Liu
Principal Investigator, Associate Professor, Department of Biochemistry and Biophysics, Perelman School of Medicine
University of Pennsylvania, USA
Michal Lotem
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Jacopo Manigrasso
Director, Nucleic Acids Department
Nostrum Biodiscovery, Barcelona, Spain
Saul Martinez Montero
Executive Director, RNA Therapeutics
Dyne Therapeutics, Boston, USA
Carsten Müller-Tidow
Director of Internal Medicine, Hematology, Oncology, Rheumatology
Heidelberg University Hospital, Heidelberg, Germany
Director of the Laboratory of Precision NanoMedicine and Vice President for Research
Tel Aviv University (TAU), Israel
Director of the Sharett Institute of Oncology
Hadassah Medical Center, Jerusalem, Israel
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, Paris, France
Associate Professor, School of Biological Sciences
Nanyang Technological University Singapore
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Rome, Italy
Director of Experimental Pathology
Children's Hospital of Philadelphia, USA
Centre Director and Professor of Neurodegeneration Research
Francis Crick Institute and King’s College London, UK
Chair, Professor, School of Life Science
Southern University of Science and Technology Shenzhen, China
Matthew White
Senior Research Fellow, Principal Investigator
King’s College London, White Lab Neuro, London, UK
TBD
WuXi AppTec, London, UK
